TCM
Tang Capital Management Portfolio holdings
AUM
$2.02B
1-Year Est. Return
102.23%
This Fund
S&P 500
1 Year Est. Return
+102.23%
AUM
$2.02B
AUM Growth
-$573M
(-22%)
Holding
201
Top Buys
| 1 | +$58.1M | |
| 2 | +$22.2M | |
| 3 | +$20.3M | |
| 4 |
BioNTech
BNTX
|
+$20.1M |
| 5 |
ANI Pharmaceuticals
ANIP
|
+$14.2M |
Top Sells
| 1 | +$94.5M | |
| 2 | +$56.5M | |
| 3 | +$42.1M | |
| 4 |
Vera Therapeutics
VERA
|
+$39.2M |
| 5 |
Nike
NKE
|
+$36.2M |
Sector Composition
| 1 | Healthcare | 96.95% |
| 2 | Technology | 1.18% |
| 3 | Communication Services | 0.76% |
| 4 | Real Estate | 0.1% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arvinas
ARVN
$870M
| $6.76M | 0.33% |
569,698
-824,102
|
|
||
52
Theravance Biopharma
TBPH
$688M
| $6.57M | 0.32% |
351,252
+86,944
|
|
||
53
BioCryst Pharmaceuticals
BCRX
$2.1B
| $6.24M | 0.31% |
800,000
|
|
||
54
PMV Pharmaceuticals
PMVP
$87.3M
| $6.17M | 0.31% |
4,940,000
+154,799
|
|
||
55
Regeneron Pharmaceuticals
REGN
$80.3B
| $6.17M | 0.31% |
8,000
-2,000
|
|
||
56
Biogen
BIIB
$27.1B
| $6.16M | 0.3% |
35,000
|
|
||
57
Corcept Therapeutics
CORT
$3.6B
| $5.46M | 0.27% |
+156,764
|
|
||
58
Abeona Therapeutics
ABEO
$263M
| $5.27M | 0.26% |
+1,000,000
|
|
||
59
ImmunityBio
IBRX
$8.91B
| $4.62M | 0.23% |
2,333,333
|
|
||
60
Kezar Life Sciences
KZR
$50.8M
| $4.18M | 0.21% |
664,314
-55,686
|
|
||
61
Coherus Oncology
CHRS
$272M
| $3.87M | 0.19% |
2,724,509
-2,372,853
|
|
||
62
Erasca
ERAS
$4.79B
| $3.35M | 0.17% |
900,000
-602,915
|
|
||
63
Nkarta
NKTX
$178M
| $2.74M | 0.14% |
1,480,823
-5,574,753
|
|
||
64
Nuvalent
NUVL
$7.82B
| $2.2M | 0.11% |
21,880
-28,120
|
|
||
65
Alexandria Real Estate Equities
ARE
$8.79B
| $1.96M | 0.1% |
40,000
|
|
||
66
Neumora Therapeutics
NMRA
$513M
| $1.73M | 0.09% |
967,235
-432,765
|
|
||
67
Sutro Biopharma
STRO
$414M
| $1.62M | 0.08% |
139,617
-143,255
|
|
||
68
Biohaven
BHVN
$1.32B
| $1.58M | 0.08% |
140,000
|
|
||
69
Revolution Medicines
RVMD
$19B
| $1.25M | 0.06% |
15,640
-84,360
|
|
||
70
Fate Therapeutics
FATE
$153M
| $1.15M | 0.06% |
1,167,773
-700,000
|
|
||
71
Zymeworks
ZYME
$1.82B
| $912K | 0.05% |
34,631
-1,065,369
|
|
||
72
Rocket Pharmaceuticals
RCKT
$477M
| $351K | 0.02% |
100,000
-750,000
|
|
||
73
Adicet Bio
ACET
$70M
| $51.9K | ﹤0.01% |
6,158
-507,818
|
|
||
74
TScan Therapeutics
TCRX
$63.6M
| $46.1K | ﹤0.01% |
46,131
-553,869
|
|
||
75
Cassava Sciences
SAVA
$98.1M
| $14K | ﹤0.01% |
7,073
|
|